PuREC Co.Ltd.

PuREC Co.Ltd.

Ultra-pure human bone marrow derived mesenchymal stem cell “REC”

Founded 2016 Japan

Japan 4 employees Series A Total: $670.00M Health Care, Health and Wellness +1

PuREC Co.Ltd. is a bio-venture company founded in 2016 with the goal of utilizing ultra-high-purity human bone marrow-derived stem cells "REC®︎" to address various intractable diseases. The company's slogan, "Ultra-pure human bone marrow derived mesenchymal stem cell “REC”", reflects its focus on innovation in the health care and pharmaceutical industries. Based in Japan, PuREC Co.Ltd. secured a significant ¥580.00M Series A investment on 19 June 2019, with backing from notable investors including Gogin Capital, Fujifilm, REVIC, and Fast Track Initiative, Inc. As a content writer and startup analyst, it's important to highlight the innovative approach of PuREC Co.Ltd. in utilizing advanced stem cell technology for therapeutic applications. The company's successful Series A funding round, led by prominent investors, demonstrates strong confidence in its potential for addressing unmet medical needs. PuREC's focus on intractable diseases and its cutting-edge technology position it well for future growth and impact in the healthcare sector.

Funding Stage	Amount	Investors	Lead Investors	Date
Series A	¥580.00M	4	Gogin Capital, Fujifilm +2	19 Jun 2019
Seed Round	¥90.00M	3	Gogin Capital, Fast Track Initiative, Inc. +1	27 Jan 2016

Funding Stage

Amount

Investors

Lead Investors

Date

Series A

¥580.00M

Gogin Capital, Fujifilm +2

19 Jun 2019

Seed Round

¥90.00M

Gogin Capital, Fast Track Initiative, Inc. +1

27 Jan 2016

FAQ About PuREC Co.Ltd.

Ultra-pure human bone marrow derived mesenchymal stem cell “REC”

PuREC Co.Ltd. was founded in 2016.

PuREC Co.Ltd. is headquartered in Japan.

PuREC Co.Ltd. operates in Health Care, Health and Wellness and Pharmaceutical. Its work centres on Bio-venture company, Stem cell therapy, Mesenchymal stem cells and Intractable diseases.

PuREC Co.Ltd. has approximately 4 employees.

PuREC Co.Ltd. has completed 2 funding rounds, raising a total of $670.00M. The latest funding stage is Series A.

Top alternatives and competitors to PuREC Co.Ltd. include Celularity Inc., Altheia Science, Garuda Therapeutics, BioRestorative Therapies, Inc., Promethera Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.

PuREC Co.Ltd. and Celularity Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

General Information

Discover More

About PuREC Co.Ltd.

Funding Rounds & Investors (2)

PuREC Co.Ltd. Alternatives & Competitors

FAQ About PuREC Co.Ltd.